Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) Total liabilities 2021–2025
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) total liabilities at each fiscal year-end, per SEC filings.
$5.2MFY2025 · since FY2021: $3.5M → $5.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.2M | +3.9% |
| FY2024 | $5.0M | +42.7% |
| FY2023 | $3.5M | +14.6% |
| FY2022 | $3.1M | -13.6% |
| FY2021 | $3.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice